Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations (Q36022963)

11 August 2017

1 reference

title

Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations (English)

1 reference

11 August 2017

0 references

Uri Elkayam

1

1 reference

11 August 2017

Fahed Bitar

2

1 reference

11 August 2017

Mohammed W Akhter

3

1 reference

11 August 2017

Salman Khan

4

1 reference

11 August 2017

Saber Patrus

5

1 reference

11 August 2017

Mahyar Derakhshani

6

1 reference

11 August 2017

1 December 2004

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

11 August 2017

1 reference

11 August 2017

9

1 reference

11 August 2017

4

1 reference

11 August 2017

227-241

1 reference

The role of organic nitrates in the treatment of heart failure

11 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Nitrates in the treatment of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Hemodynamic and volumetric effects of venodilation with nitroglycerin in chronic mitral regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Prevention and reversal of nitrate tolerance in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Role of superoxide dismutase in in vivo and in vitro nitrate tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

The reaction of no with superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Dietary supplement with vitamin C prevents nitrate tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Dissociation of nitrovasodilator-induced relaxation from cyclic GMP levels during in vitro nitrate tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Nitrate tolerance: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Guidelines for acute decompensated heart failure treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900403

10.1177/107424840400900403

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference